Living at higher altitudes in India is linked to an increased risk of stunted growth, with children living in homes 2000 metres or more above sea level 40% more at risk than those living 1000 metres below, finds research published in the open access journal BMJ Nutrition Prevention & Health.
Bayer, Cytokinetics make a deal in Japan; Ex-Carmot CEO to run LB Pharmaceuticals
Plus, news about Spyre, Tongrui Biotech, ATB Therapeutics, Freya Biosciences, Intas and Xbrane: Bayer, Cytokinetics ink deal for heart drug in Japan: The German drugmaker